Rift Valley Fever Testing Market Opportunities, Key Growth Factors, Ongoing Trends, Market Perspective and Forecast till 2028

Posted on 2018-07-24 by Mark Hub in Healthcare // 0 Comments

Rockville, US, 2018-Jul-24 — /EPR Network/ — Rift Valley Fever is an acute mosquito born viral disease caused by a virus belonging to the family Bunyaviridae and the genus Phlebovirus. It is a fever causing virus which most commonly affects domesticated animals, such as cattle, buffalo, sheep, goats and camel. The virus also has the ability to infect and cause illnesses in human beings. Rift valley fever was first reported in livestock by veterinary officers in Kenya’s Rift Valley in the early 1910’s. Rift valley fever exists in most of the sub-saharan Africa, Western Africa and Madagascar, but it is also found in the Eastern and Southern regions of Africa where sheep and cattle are reared. Rift valley fever outbreak was also reported in Saudi Arabia in September, 2000. Outbreaks of rift valley fever increase the likelihood of contact between humans and deceased animals, which can lead to an epidemic of rift valley fever in humans. In 1977, the virus was detected in Egypt and caused a large outbreak in both humans and animals, resulting in over 600 human deaths in the country.

Rift Valley Fever Testing Market: Drivers and Restraints

Although rift valley fever is only confined to Middle-East and Africa, it can easily spread to other countries. The incidences of rift valley fever peak in the summer, which is essentially the season when the virus gets optimum conditions to grow. Increasing incidence rates and prevalence of rift valley fever are the major factors expected to drive the rift valley testing market during the forecast period. However, costs associated with the diagnostic testing in Middle-East and Africa is a leading restraining factor that might hinder the growth of the rift valley fever testing market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1096

Rift Valley Fever Testing Market: Segmentation

Tentatively, the rift valley fever testing market has been segmented on the basis of test type, end users and region.

Based on test type, the global rift valley fever testing market is segmented into:

Reverse transcriptase polymerase chain reaction (RT-PCR) assay.
IgG and IgM antibody enzyme-linked immunosorbent assay (ELISA)

Based on end user, the global rift valley fever testing market is segmented into:

Diagnostic Centers
Veterinary Clinics
Research Laboratories

Based on region, the global rift valley fever testing market is segmented into:

North America
Latin America
Western Europe
Eastern Europe
China
Japan
Asia Pacific
Middle East & Africa

Rift Valley Fever Testing Market: Overview

The global market for rift valley fever testing is highly competitive with various players operating in the global space. Both the test types — reverse transcriptase PCR and ELISA — are some of the most common techniques used in research, clinical diagnosis and related markets. Some of the established brands of rift valley fever testing are Thermo Fisher Scientific, Inc. (U.S), Merck KGaA (Germany), New England Biolabs, Inc., (U.S), Promega (U.S), Illumina, Inc, Agilent Technologies, Inc. (U.S.) and F.Hoffmann-la Roche Ltd. (Switzerland).

To know more about the Rift Valley Fever Testing Market Trends, Visit the link – https://www.factmr.com/report/1096/rift-valley-fever-testing-market

Rift Valley Fever Testing Market: Regional Wise Outlook

Geographically, the global rift valley fever testing market is classified into 8 regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, China, Japan, Middle East and Africa. North America is expected to be a leader in rift valley fever testing market owing to concentration of key market players in the region. The market in Middle East & Africa and Asia Pacific is expected to grow at significant CAGR due to expansion of rift valley fever product offerings by key players. Europe is expected to hold the second largest share in the global rift valley fever testing market throughout the forecast period.

Rift Valley Fever Testing Market: Key Players

Examples of some of the major players in the rift valley fever testing market are Thermo Fisher Scientific, Inc. (U.S), Merck KGaA (Germany), New England Biolabs, Inc., (U.S), Promega (U.S), Illumina, Inc, Agilent Technologies, Inc. (U.S.), F.Hoffmann-la Roche Ltd. (Switzerland), Takara Bio, Inc. (Japan), QIAGEN N.V. (The Netherlands), Becton, Dickson and Company (U.S), Biocartis NV (Belgium), Bioline Reagents Limited (United Kingdom), Dnavision SA (Belgium), Eppendorf AG (Germany) and Exiqon A/S (Denmark).

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific (India, Australia & New Zealand)
Japan
China
Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Pre-book this Report- https://www.factmr.com/checkout/1096/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick